POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
When do Potassium Chloride 20meq In Dextrose 5% In Plastic Container patents expire, and when can generic versions of Potassium Chloride 20meq In Dextrose 5% In Plastic Container launch?
Potassium Chloride 20meq In Dextrose 5% In Plastic Container is a drug marketed by Baxter Hlthcare, Fresenius Kabi Usa, and Icu Medical Inc. and is included in eleven NDAs.
The generic ingredient in POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% IN PLASTIC CONTAINER is dextrose; potassium chloride. There are nine drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the dextrose; potassium chloride profile page.
Summary for POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% IN PLASTIC CONTAINER
US Patents: | 0 |
Applicants: | 3 |
NDAs: | 11 |
Finished Product Suppliers / Packagers: | 3 |
Formulation / Manufacturing: | see details |
DailyMed Link: | POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% IN PLASTIC CONTAINER at DailyMed |
Pharmacology for POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% IN PLASTIC CONTAINER
Drug Class | Osmotic Laxative Potassium Salt |
Mechanism of Action | Osmotic Activity |
Physiological Effect | Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption |